XTend said upon final approval from FINRA and other regulatory agencies, the name change will be effective.

XTend Medical CEO Paul Lisenby said the decision to change the name of the company to MultiCorp International is based on the company’s plans to acquire companies that have opportunities in many varying sectors in today’s business world.

"The company will continue to be deeply involved in the medical field," Lisenby added.

"The share structure will remain intact and no reverse split or any other changes will be made to the company."

XTend Medical operates its core business in the medical field but also has divisions within the company in varying business sectors.